Avai Bio, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVAI research report →
Price Chart
About the company
Avai Bio, Inc. operates as a holding company primarily focused on creating websites and mobile applications that offer users personalized and convenient experiences. Its business activities include providing IT consulting services and making artificial intelligence accessible to the general public.
- CEO
- Chris Winter
- IPO
- 2020
- Employees
- 1
- HQ
- Vilnius, NV, LT
Get TickerSpark's AI analysis on AVAI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $16.59M
- P/E
- -9.45
- PEG
- 0.14
- P/S
- 0.00
- P/B
- -5.73
- EV/EBITDA
- -12.92
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 65.17%
- ROIC
- 151.48%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-26,070+64.9%
- Op Income
- $-1,480,191
- Net Income
- $-1,749,509-53.2%
- EPS
- $-0.01-42.7%
- OCF Growth
- +13.0%
- FCF Growth
- +13.0%
- 52W High
- $0.80
- 52W Low
- $0.10
- 50D MA
- $0.13
- 200D MA
- $0.28
- Beta
- 0.87
- RSI (14)
- 46
- Avg Volume
- 124.04K
No earnings-call transcripts are available for AVAI yet.
- Free Float
- 61.0%
- Shares Outstanding
- 153.92M
- Float Shares
- 84.38M
Our AVAI coverage
Recent articles, reports, and earnings notes.
No research on AVAI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AVAI report →Avaí Bio and Austrianova Successfully Encapsulate GMP-Quality Klotho-Producing Cells, Achieve Robust Klotho Secretion
globenewswire.com · Sep 30
Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference
globenewswire.com · Sep 24
Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy
globenewswire.com · Sep 15
Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy
globenewswire.com · Sep 15
Avant Brands Completes EU GMP Audit at Flowr Facility
accessnewswire.com · Aug 20
Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes
globenewswire.com · Aug 12
Avant Brands Completes Major LED Lighting Retrofit at its 80,000 Sq Ft Flowr Facility, Delivering Significant Energy Savings & Production Gains
accessnewswire.com · Jul 22
Avaí Bio and Austrianova Reach Agreement for Insulin-Producing Cells with Internationally Acclaimed Partner to Advance Diabetes Therapy
prnewswire.com · Jul 21
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.